from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2085/-

LFCtreatmentdescriptionclass of inhibitor

0.072

Amikacinug/mL Amikacintranslation

-0.460

Cap5-10ug/mL Capreomycintranslation

-0.155

Rox10-50 ug/mL Roxithromycintranslation

1.097

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

1.568

Rif0.2-5ug/mL Rifampicintranscription

0.614

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.308

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.700

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.160

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.461

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.636

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.546

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.137

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-2.049

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.371

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.103

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-2.789

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.439

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.932

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.187

Nigericin50 uM Nigericinrespiration

-0.186

TRC10-150 ug/mL Triclosanrespiration

-0.162

TRZ10-25 ug/mL Thioridazinerespiration

-0.048

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.197

menadione6-10 ug/mL Menadionerespiration

0.167

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.437

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.461

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.294

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.845

NRP_1Non-replicating persistence stage 1dosRassociated

0.039

Amp0.2mg/mL AmpicillincellWall

0.153

Cephalexin20-100 ug/mL CephalexincellWall

0.425

Cerulenin0.32-5 ug/mL CerulenincellWall

0.449

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.085

EMB10-20 ug/mL EthambutolcellWall

-0.640

Eta12-40 ug/mL EthionamidecellWall

-0.927

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.039

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.192

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.898

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.130

BZA0.12 mg/mL BenzamidearomaticAmides

-0.168

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.290

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.684

H2O24 mM hydrogen peroxideDNAdamaging

-0.050

Levo10 ug/mL LevofloxacinDNAdamaging

0.425

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.676

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.152

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.196

UVUV-irradiationDNAdamaging

-0.156

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.973

Antimycin12.5-50 ug/mL Antimycin A?

0.374

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.390

PA_110-50 ug/mL Antitubercular compound PA-1?

0.639

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.732

PA8240.2-2 ug/mL PA-824?

-0.715

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.379

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.117

Verapamil50 uM Verapamil?

0.238

mercaptoethanol2 mM 2-Mercaptoethanol?

0.280

methoxatin10-20 ug/mL Methoxatin?